Growth Metrics

Astria Therapeutics (ATXS) Total Non-Current Liabilities: 2018

Historic Total Non-Current Liabilities for Astria Therapeutics (ATXS) over the last 1 years, with Dec 2018 value amounting to $4.2 million.

  • Astria Therapeutics' Total Non-Current Liabilities was N/A to $4.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $4.2 million, marking a year-over-year change of. This contributed to the annual value of $4.2 million for FY2018, which is N/A change from last year.
  • Latest data reveals that Astria Therapeutics reported Total Non-Current Liabilities of $4.2 million as of FY2018.
  • Astria Therapeutics' Total Non-Current Liabilities' 5-year high stood at $4.2 million during FY2018, with a 5-year trough of $4.2 million in FY2018.
  • For the 1-year period, Astria Therapeutics' Total Non-Current Liabilities averaged around $4.2 million, with its median value being $4.2 million (2018).